[go: up one dir, main page]

Price et al., 1947 - Google Patents

The urinary excretion of penicillins G and K in rabbits

Price et al., 1947

Document ID
13196568041042852097
Author
Price C
Randall W
Welch H
Publication year
Publication venue
Journal of the American Pharmaceutical Association (Scientific ed.)

External Links

Snippet

Results of experiments designed to determine the fate of penicillins G and K from the rate and total amount of urinary excretion of these fractions in rabbits are reported. Comparative data on the rate of excretion, blood levels, and relative effectiveness of penicillins G and K …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions
    • Y10S514/867—Diarrhea

Similar Documents

Publication Publication Date Title
Smith The disturbance of the normal bacterial ecology by the administration of antibiotics with the development of new clinical syndromes
DE3619702A1 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF STOMESTRAL DISEASES
JPS6234731B2 (en)
Bowmer et al. Single-dose ceftriaxone for chancroid
Leisewitz et al. The diagnosis and management of snakebite in dogs-a southern African perspective
Eykyn The therapeutic use of metronidazole in anaerobic infection: six years' experience in a London hospital
Norrby et al. Interaction between cephaloridine and furosemide in man
Nahmias et al. Epidemiology and treatment of chronic staphylococcal infections in the household
Faget et al. The therapeutic effect of promin in leprosy
Decker et al. Respiratory arrest in myasthenia gravis with colistimethate therapy
Price et al. The urinary excretion of penicillins G and K in rabbits
Menday et al. Intravenous fusidic acid ('Fucidin') in the management of severe staphylococcal infections: a review of 46 cases
GB1585863A (en) Pharmaceutical lactobacillus preparations
DE2334376A1 (en) IMMUNOLOGICAL PRODUCT, ITS USE AND METHOD FOR ITS MANUFACTURING
Clark Jr et al. Effect of Actinospectacin (Trobicin) in Experimental Syphilis in the Rabbit—II: II. IN SUBCLINICAL INCUBATING SYPHILIS
DE10163602A1 (en) Composition for treating allergic diseases, e.g. dermatitis, psoriasis, asthma or allergic rhinitis, comprises parasitic worm preparation
Croydon Clinical Experience of Amoxycillin in the United Kingdom.
Knott et al. Penicillin sprays and upper respiratory tract infection
Bentley et al. Lincomycin in the treatment of penicillin-resistant staphylococcal infections in children
SILVERMAN et al. Toxic effects of diodoquin
DE19828596A1 (en) Use of polyvalent bacteriophages
Carson et al. Vitamin C and the common cold
RU2200580C1 (en) Method for treating bronchopneumonia in calves
Randall et al. The effect of serum and organ emulsions on penicillin fractions
Levens Clonidine in treatment of dysmenorrhea